Pharmos (PARS) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Pharmos (PARS)

PARS 2.700

+13.6%

Jan 21 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Archie Meeties who wrote (1295)	11/17/2004 6:37:47 PM
From: Clarksterh	Read Replies (1) of 1386

I'll give a simpler explanation for the wide range of results on cognitive decline after cabg. Outcome depends on whether the studies are conducted by CT surgeons or by ICU attendings I'll admit that the state of affairs is moderately humorous in a pathetic sort of way, but I find it significantly irritating to see something so important completely bungled. I would suggest that you may be right that the thing the competent studies have in common is the right sort of study conductors - however I would suggest that it is more about having lots of neuropsychologists and fewer cardiac surgeons. (Speculation on my part - but would you go to your Cardiologist when you were feeling 'fuzzy'?) And it isn't at all clear that Pharmos understood this difficulty when designing their exploratory study. So I'll bet they are having an interesting time trying to mine gold from a bunch of very noisy data. I hope I am wrong, but as November goes on with no word I tend to think that is some confirmation since mining gold from garbage is difficult. Good thing I am much more confident about the upcoming TBI study! Clark

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next